Related Experiment Video
Updated: Jul 20, 2025

Author Spotlight: Innovative Techniques for ROS Detection and Implications for Platelet Research
Published on: March 29, 2024
Targeting oxidative stress as a preventive and therapeutic approach for cardiovascular disease
Qian Yan1, Shasha Liu2, Yang Sun1
1Hunan Engineering Technology Center of Standardization and Function of Chinese Herbal Decoction Pieces, College of Pharmacy, Hunan University of Chinese Medicine, Changsha, 410208, China.
Insights
Herbal monomers combat oxidative stress in cardiovascular diseases (CVDs) by boosting antioxidant systems and reducing reactive oxygen species (ROS). These compounds offer a promising therapeutic strategy for protecting heart health against oxidative damage.
Area of Science:
- Cardiology
- Biochemistry
- Pharmacology
Background:
- Cardiovascular diseases (CVDs) are a leading cause of global mortality.
- Oxidative stress (OS) is a key factor in the development and progression of CVDs.
- Balancing reactive oxygen species (ROS) and antioxidants is vital for cardiac health.
Purpose of the Study:
- To review the mechanisms of OS and its link to CVDs.
- To explore the therapeutic potential of herbal monomers as antioxidants for CVDs.
- To examine the cardioprotective effects of herbal monomers on cardiac signaling pathways.
Main Methods:
- Literature review on oxidative stress mechanisms.
- Analysis of the role of OS in cardiovascular disease pathogenesis.
- Evaluation of studies on herbal monomers' antioxidant and cardioprotective actions.
Main Results:
- Herbal monomers can mitigate OS by enhancing endogenous antioxidant systems.
- These compounds reduce ROS levels, thereby protecting cardiac function.
- Herbal monomers demonstrate significant cardioprotective effects by modulating signaling pathways.
Conclusions:
- Herbal monomers represent a promising therapeutic avenue for managing oxidative stress in CVDs.
- Targeting OS with herbal monomers can help preserve cardiac function and reduce disease progression.
- Further research into specific herbal monomers and their mechanisms is warranted for clinical application.
Abstract:
Cardiovascular diseases (CVDs) continue to exert a significant impact on global mortality rates, encompassing conditions like pulmonary arterial hypertension (PAH), atherosclerosis (AS), and myocardial infarction (MI). Oxidative stress (OS) plays a crucial role in the pathogenesis and advancement of CVDs, highlighting its significance as a contributing factor. Maintaining an equilibrium between reactive oxygen species (ROS) and antioxidant systems not only aids in mitigating oxidative stress but also confers protective benefits on cardiac health. Herbal monomers can inhibit OS in CVDs by activating multiple signaling pathways, such as increasing the activity of endogenous antioxidant systems and decreasing the level of ROS expression. Given the actions of herbal monomers to significantly protect the normal function of the heart and reduce the damage caused by OS to the organism. Hence, it is imperative to recognize the significance of herbal monomers as prospective therapeutic interventions for mitigating oxidative damage in CVDs. This paper aims to comprehensively review the origins and mechanisms underlying OS, elucidate the intricate association between CVDs and OS, and explore the therapeutic potential of antioxidant treatment utilizing herbal monomers. Furthermore, particular emphasis will be placed on examining the cardioprotective effects of herbal monomers by evaluating their impact on cardiac signaling pathways subsequent to treatment.
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease IV: Preventive Measures
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Radical Autoxidation
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Atherosclerosis III: Management

